Global Nanobodies Market Report By Product Type (Mono-specific, Monovalent, Multivalent, Bi-paratopic, Multi-specific), By Indication (Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Respiratory Syncytial Virus (RSV) Infection, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Oncology, Immune Mediated Inflammatory Diseases (IMID), Psoriasis, Chronic Kidney Diseases, Bone Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212702
April 2021
Report Formats:
The global demand for Nanobodies Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Nanobodies are a novel class of proprietary therapeutic proteins based on single-domain antibody fragments. It contains the unique structural and functional properties of naturally-occurring heavy-chain antibodies. These are small, recombinantly produced antigen-binding VHH fragments, derived from the Alpaca heavy chain IgG antibody (HCA). Due to their tiny size and unique structure, Nanobodies are ideal building blocks for the generation of novel biological drugs with multiple competitive advantages over other therapeutic molecules. The most common uses of nanobodies are for experiments like immunoprecipitation, or fluorescence microscopy.
 
Market Dynamics
 
The growing biologics and therapeutic research and FDA approval provide many opportunities to investigate nanobodies and their interaction with others, thereby lifting hopes for exploring innovative uses. In recent years, nanobodies have become indispensable therapeutic and research tools due to the growing burden of cancer, immune-mediated inflammatory and other diseases. Nanobodies is a lucrative approach for oncology therapeutics research as it inhibits tumor growth, protects the body against systemic toxicity, and allows solubilization of hydrophobic drug in hydrophilic structures. They are researched against a diverse range of disorders and capable of being employed in various situations. Recognizing the potential, companies engaged in therapeutic research are adopting different collaborative research strategies to develop and commercialize nanobody-based therapeutics.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of nanobodies.
 
Market Segmentation
 
The entire nanobodies market has been sub-categorized into product type, indication and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Product Type
  • Mono-specific
  • Monovalent
  • Multivalent
  • Bi-paratopic
  • Multi-specific
 
By Indication
  • Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
  • Respiratory Syncytial Virus (RSV) Infection
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Oncology
  • Immune Mediated Inflammatory Diseases (IMID)
  • Psoriasis
  • Chronic Kidney Diseases
  • Bone Disorders
  • Others
 
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for nanobodies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Nanobodies Market Share by Region (Representative Graph)
 
Global Nanobodies Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the nanobodies market include Novo Nordisk A/S, Merck & Co., Inc., Merck KgaA, AbbVie, Inc., C.H. Boehringer Sohn AG & Ko. KG., Ablynx. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Nanobodies Market
       2.2. Global Nanobodies Market Snapshot
 
3 . NANOBODIES – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Nanobodies Market
       3.3. Market Restraints of Nanobodies Market
       3.4. Opportunities of Nanobodies Market
       3.5. Trends of Nanobodies Market
       3.6. Porter’s Five Force Analysis of Nanobodies Market
       3.7. Nanobodies Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product Type
           3.7.2 Market Attractive Analysis by Indication
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Nanobodies Value Chain Analysis
       4.2. Nanobodies Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Nanobodies Raw Material Manufactures List
           4.2.3. Price Trend of Nanobodies Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Nanobodies Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Nanobodies Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Nanobodies Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Nanobodies Market
 
6 . GLOBAL NANOBODIES MARKET ANALYSIS BY PRODUCT TYPE
       6.1 Overview by Product Type
       6.2 Historical Data 2015-2018
       6.3 Global Nanobodies Market Analysis by Product Type
       6.4 Market Analysis of Mono-specific by Regions
       6.6 Market Analysis of Monovalent by Regions
       6.5 Market Analysis of Multivalent by Regions
       6.7 Market Analysis of Bi-paratopic by Regions
       6.8 Market Analysis of Multi-specific by Regions
 
7 . GLOBAL NANOBODIES MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical Data 2015-2018
       7.3 Global Nanobodies Market Analysis by Indication
       7.4 Market Analysis of Acquired Thrombotic Thrombocytopenic Purpura (aTTP) by Regions
       7.5 Market Analysis of Respiratory Syncytial Virus (RSV) Infection by Regions
       7.6 Market Analysis of Rheumatoid Arthritis by Regions
       7.7 Market Analysis of Systemic Lupus Erythematosus by Regions
       7.8 Market Analysis of Oncology by Regions
       7.9 Market Analysis of Immune mediated Inflammatory Diseases (IMID) by Regions
       7.10. Market Analysis of Psoriasis by Regions
       7.11 Market Analysis of Chronic Kidney Diseases by Regions
       7.12 Market Analysis of Bone Disorders by Regions
       7.13 Market Analysis of Others by Regions
 
8 . GLOBAL NANOBODIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Historical Data 2015-2018
       8.3 Global Nanobodies Market Analysis by Distribution Channel
       8.4 Market Analysis of Hospital Pharmacies by Regions
       8.5 Market Analysis of Retail Pharmacies by Regions
       8.6 Market Analysis of Online Pharmacies by Regions
 
9 . GLOBAL NANOBODIES MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview and Historic Data
           9.3.2. North America Nanobodies Market Estimate By Market Segment
           9.3.3. North America Nanobodies Market Estimate By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview and Historic Data
           9.4.2. Europe Nanobodies Market Estimate by Market Segment
           9.4.3. Europe Nanobodies Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview and Historic Data
           9.5.2. Asia Pacific Nanobodies Market Estimate by Market Segment
           9.5.3. Asia Pacific Nanobodies Market Estimate by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview and Historic Data
           9.6.2. Latin America Nanobodies Market Estimate by Market Segment
           9.6.3. Latin America Nanobodies Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview and Historic Data
           9.7.2. Middle East & Africa Nanobodies Market Estimate by Market Segment
           9.7.3. Middle East & Africa Nanobodies Market Estimate by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE NANOBODIES COMPANIES
       10.1. Nanobodies Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF NANOBODIES INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Novo Nordisk A/S
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Merck & Co., Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Merck KgaA
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. AbbVie, Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. C.H. Boehringer Sohn AG & Ko. KG.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Ablynx
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Nanobodies Market Snapshot
  • Drivers of The Global Nanobodies Market Impact Analysis
  • Restraints of The Global Nanobodies Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Nanobodies Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Nanobodies Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Nanobodies Market
  • Global Nanobodies Market Analysis by Product Type (USD MN)
  • Historic Data 2015-2018
  • Global Nanobodies Market Analysis in Mono-specific by Geography (USD MN)
  • Global Nanobodies Market Analysis in Monovalent by Geography (USD MN)
  • Global Nanobodies Market Analysis in Multivalent by Geography (USD MN)
  • Global Nanobodies Market Analysis in Bi-paratopic by Geography (USD MN)
  • Global Nanobodies Market Analysis in Multi-specific by Geography (USD MN)
  • Global Nanobodies Market Analysis by Indication (USD MN)
  • Historic Data 2015-2018
  • Global Nanobodies Market Analysis in Acquired Thrombotic Thrombocytopenic Purpura (aTTP) by Geography (USD MN)
  • Global Nanobodies Market Analysis in Respiratory Syncytial Virus (RSV) Infection by Geography (USD MN)
  • Global Nanobodies Market Analysis in Rheumatoid Arthritis by Geography (USD MN)
  • Global Nanobodies Market Analysis in Systemic Lupus Erythematosus by Geography (USD MN)
  • Global Nanobodies Market Analysis in Oncology by Geography (USD MN)
  • Global Nanobodies Market Analysis in Immune mediated Inflammatory Diseases (IMID) by Geography (USD MN)
  • Global Nanobodies Market Analysis in Psoriasis by Geography (USD MN)
  • Global Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Historic Data 2015-2018
  • Global Nanobodies Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Nanobodies Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Nanobodies Market Analysis in Online Pharmacies by Geography (USD MN)
  • Historic Data 2015-2018
  • Global Nanobodies Market by Geography (USD MN)
  • Historic Data 2015-2018
  • North America Nanobodies Market Analysis by Product Type (USD MN)
  • North America Nanobodies Market Estimate by Indication (USD MN)
  • North America Nanobodies Market Analysis by Distribution Channel (USD MN)
  • North America Nanobodies Market Estimate by Country (USD MN)
  • United State Nanobodies Market Analysis by Product Type (USD MN)
  • United State Nanobodies Market Estimate by Indication (USD MN)
  • United State Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Canada Nanobodies Market Analysis by Product Type (USD MN)
  • Canada Nanobodies Market Estimate by Indication (USD MN)
  • Canada Nanobodies Market Estimate by Distribution Channel (USD MN)
  • Mexico Nanobodies Market Analysis by Product Type (USD MN)
  • Mexico Nanobodies Market Estimate by Indication (USD MN)
  • Mexico Nanobodies Market Estimate by Distribution Channel (USD MN)
  • Europe Nanobodies Market Analysis by Product Type (USD MN)
  • Europe Nanobodies Market Estimate by Indication (USD MN)
  • Europe Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Europe Nanobodies Market Estimate by Country (USD MN)
  • United Kingdom Nanobodies Market Analysis by Product Type (USD MN)
  • United Kingdom Nanobodies Market Estimate by Indication (USD MN)
  • United Kingdom Nanobodies Market Analysis by Distribution Channel (USD MN)
  • France Nanobodies Market Analysis by Product Type (USD MN)
  • France Nanobodies Market Estimate by Indication (USD MN)
  • France Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Germany Nanobodies Market Analysis by Product Type (USD MN)
  • Germany Nanobodies Market Estimate by Indication (USD MN)
  • Germany Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Italy Nanobodies Market Analysis by Product Type (USD MN)
  • Italy Nanobodies Market Estimate by Indication (USD MN)
  • Italy Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Russia Nanobodies Market Analysis by Product Type (USD MN)
  • Russia Nanobodies Market Estimate by Indication (USD MN)
  • Russia Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Spain Nanobodies Market Analysis by Product Type (USD MN)
  • Spain Nanobodies Market Estimate by Indication (USD MN)
  • Spain Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Rest of Europe Nanobodies Market Analysis by Product Type (USD MN)
  • Rest of Europe Nanobodies Market Estimate by Indication (USD MN)
  • Rest of Europe Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Asia Pacific Nanobodies Market Analysis by Product Type (USD MN)
  • Asia Pacific Nanobodies Market Estimate by Indication (USD MN)
  • Asia Pacific Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Asia Pacific Nanobodies Market Estimate by Country (USD MN)
  • China Nanobodies Market Analysis by Product Type (USD MN)
  • China Nanobodies Market Estimate by Indication (USD MN)
  • China Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Japan Nanobodies Market Analysis by Product Type (USD MN)
  • Japan Nanobodies Market Estimate by Indication (USD MN)
  • Japan Nanobodies Market Analysis by Distribution Channel (USD MN)
  • India Nanobodies Market Analysis by Product Type (USD MN)
  • India Nanobodies Market Estimate by Indication (USD MN)
  • India Nanobodies Market Analysis by Distribution Channel (USD MN)
  • South Korea Nanobodies Market Analysis by Product Type (USD MN)
  • South Korea Nanobodies Market Estimate by Indication (USD MN)
  • South Korea Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Australia Nanobodies Market Analysis by Product Type (USD MN)
  • Australia Nanobodies Market Estimate by Indication (USD MN)
  • Australia Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Rest of Asia Pacific Nanobodies Market Analysis by Product Type (USD MN)
  • Rest of Asia Pacific Nanobodies Market Estimate by Indication (USD MN)
  • Rest of Asia Pacific Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Latin America Nanobodies Market Analysis by Product Type (USD MN)
  • Latin America Nanobodies Market Estimate by Indication (USD MN)
  • Latin America Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Latin America Nanobodies Market Estimate by Country (USD MN)
  • Brazil Nanobodies Market Analysis by Product Type (USD MN)
  • Brazil Nanobodies Market Estimate by Indication (USD MN)
  • Brazil Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Argentina Nanobodies Market Analysis by Product Type (USD MN)
  • Argentina Nanobodies Market Estimate by Indication (USD MN)
  • Argentina Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Peru Nanobodies Market Analysis by Product Type (USD MN)
  • Peru Nanobodies Market Estimate by Indication (USD MN)
  • Peru Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Chile Nanobodies Market Analysis by Product Type (USD MN)
  • Chile Nanobodies Market Estimate by Indication (USD MN)
  • Chile Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Rest of Latin America Nanobodies Market Analysis by Product Type (USD MN)
  • Rest of Latin America Nanobodies Market Estimate by Indication (USD MN)
  • Rest of Latin America Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Middle East & Africa Nanobodies Market Analysis by Product Type (USD MN)
  • Middle East & Africa Nanobodies Market Estimate by Indication (USD MN)
  • Middle East & Africa Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Middle East & Africa Nanobodies Market Estimate by Country (USD MN)
  • Saudi Arabia Nanobodies Market Analysis by Product Type (USD MN)
  • Saudi Arabia Nanobodies Market Estimate by Indication (USD MN)
  • Saudi Arabia Nanobodies Market Analysis by Distribution Channel (USD MN)
  • UAE Nanobodies Market Analysis by Product Type (USD MN)
  • UAE Nanobodies Market Estimate by Indication (USD MN)
  • UAE Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Israel Nanobodies Market Analysis by Product Type (USD MN)
  • Israel Nanobodies Market Estimate by Indication (USD MN)
  • Israel Nanobodies Market Analysis by Distribution Channel (USD MN)
  • South Africa Nanobodies Market Analysis by Product Type (USD MN)
  • South Africa Nanobodies Market Estimate by Indication (USD MN)
  • South Africa Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Rest of Middle East and Africa Nanobodies Market Analysis by Product Type (USD MN)
  • Rest of Middle East and Africa Nanobodies Market Estimate by Indication (USD MN)
  • Rest of Middle East and Africa Nanobodies Market Analysis by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Nanobodies Report
  • Market Research Process
  • Market Research Methodology
  • Global Nanobodies Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Nanobodies Market Analysis by Product Type
  • Global Nanobodies Market Analysis in Mono-specific by Region
  • Global Nanobodies Market Analysis in Monovalent by Region
  • Global Nanobodies Market Analysis in Multivalent by Region
  • Global Nanobodies Market Analysis in Bi-paratopic by Region
  • Global Nanobodies Market Analysis in Multi-specific by Region
  • Global Nanobodies Market Analysis by Indication
  • Global Nanobodies Market Analysis in Acquired Thrombotic Thrombocytopenic Purpura (aTTP) by Region
  • Global Nanobodies Market Analysis in Respiratory Syncytial Virus (RSV) Infection by Region
  • Global Nanobodies Market Analysis in Rheumatoid Arthritis by Region
  • Global Nanobodies Market Analysis in Systemic Lupus Erythematosus by Region
  • Global Nanobodies Market Analysis in Oncology by Region
  • Global Nanobodies Market Analysis in Immune mediated Inflammatory Diseases (IMID) by Region
  • Global Nanobodies Market Analysis in Psoriasis by Region
  • Global Nanobodies Market Analysis by Distribution Channel
  • Global Nanobodies Market Analysis in Hospital Pharmacies by Region
  • Global Nanobodies Market Analysis in Retail Pharmacies by Region
  • Global Nanobodies Market Analysis in Online Pharmacies by Region
  • Global Nanobodies Market by Revenue
  • North America Nanobodies Market by Revenue
  • Europe Nanobodies Market by Revenue
  • Asia Pacific Nanobodies Market by Revenue
  • Latin America Nanobodies Market by Revenue
  • Middle East & Africa Nanobodies Market by Revenue
  • Recent Development in Nanobodies Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials